For example, TOP2A displaying the most significant upregulation has been identified as a biomarker for HBV-related HCC (Liao et al., 2019) and APOF with the most significant downregulation is considered a tumor suppressor in HCC (Wang Y. B. et al., 2019). The gene discussed is TOP2A; the disease is hepatocellular carcinoma.